Information Provided By:
Fly News Breaks for November 6, 2019
GBT
Nov 6, 2019 | 05:57 EDT
Canaccord analyst John Newman initiated coverage of Global Blood Therapeutics with a Hold rating and $50 price target.
News For GBT From the Last 2 Days
There are no results for your query GBT